Pharmaceutical Care on One Atrial Fibrillation Patient with Coronary Artery Disease with Elevated INR Caused by Warfarin
- VernacularTitle:房颤合并冠心病患者服用华法林致INR异常1例的药学监护
- Author:
Ying WANG
;
Xiangping TAN
;
Pengke YAN
- Publication Type:Journal Article
- Keywords:
Warfarin;
INR;
Atrial fibrillation;
Coronary artery disease;
Pharmaceutical care
- From:
China Pharmacist
2015;(1):105-107,108
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the content and model for clinical pharmacists to carry out pharmaceutical care on elderly pa-tients with atrial fibrillation combined with other diseases treated by warfarin. Methods:One case of an elderly atrial fibrillation patient complicated with coronary artery disease and urinary tract infection suffering elevated INR after the use of warfarin was applied as the example. The pharmaceutical care was carried out by clinical pharmacists including analyzing the causes of elevated INR and assisting the doctor to develop the individualized pharmaceutical care plan. Results: After the adjustment of warfarin dose and the other drugs combined with medical education, bleeding and thromboembolic events did not occur during the hospitalization, and finally, satisfactory effect of anticoagulation therapy was achieved. Conclusion: The implementation of pharmaceutical care on anticoagulation in atrial fi-brillation patients with various diseases is helpful to improve the compliance in patients, avoid the occurrence of adverse drug reactions and guarantee the effectiveness and safety of warfarin.
